Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Pasternak, GW' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 116 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. King, M; Su, W; Chang, A; Zuckerman, A; Pasternak, GW
      Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs

      NATURE NEUROSCIENCE
    2. Abbadie, C; Pasternak, GW
      Differential in vivo internalization of MOR-1 and MOR-1C by morphine

      NEUROREPORT
    3. Abbadie, C; Pasternak, GW; Aicher, SA
      Presynaptic localization of the carboxy-terminus epitopes of the mu opioidreceptor splice variants MOR-1C and MOR-1D in the superficial laminae of the rat spinal cord

      NEUROSCIENCE
    4. Mathis, JP; Mandyam, CD; Altememi, GF; Pasternak, GW; Standifer, KM
      Orphanin FQ/nociceptin and naloxone benzoylhydrazone activate distinct receptors in BE(2)-C human neuroblastoma cells

      NEUROSCIENCE LETTERS
    5. King, MA; Bradshaw, S; Chang, AH; Pintar, JE; Pasternak, GW
      Potentiation of opioid analgesia in dopamine(2) receptor knock-out mice: Evidence for a tonically active anti-opioid system

      JOURNAL OF NEUROSCIENCE
    6. Mogil, JS; Pasternak, GW
      The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family

      PHARMACOLOGICAL REVIEWS
    7. Pan, YX; Xu, A; Mahurter, L; Bolan, E; Xu, MM; Pasternak, GW
      Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    8. Pasternak, GW
      Insights into mu opioid pharmacology - The role of mu opioid receptor subtypes

      LIFE SCIENCES
    9. Silva, RM; Hadjimarkou, MM; Rossi, GC; Pasternak, GW; Bodnar, RJ
      beta-endorphin-induced feeding: Pharmacological characterization using selective opioid antagonists and antisense probes in rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    10. Neilan, CL; Nguyen, TMD; Schiller, PW; Pasternak, GW
      Pharmacological characterization of the dermorphin analog [Dmt(1)]DALDA, ahighly potent and selective mu-opioid peptide

      EUROPEAN JOURNAL OF PHARMACOLOGY
    11. Shane, R; Lazar, DA; Rossi, GC; Pasternak, GW; Bodnar, RJ
      Analgesia elicited by OFQ/nociceptin and its fragments from the amygdala in rats

      BRAIN RESEARCH
    12. Mathis, JP; Rossi, GC; Pellegrino, MJ; Jimenez, C; Pasternak, GW; Allen, RG
      Carboxyl terminal peptides derived from prepro-orphanin FQ/nociceptin (ppOFQ/N) are produced in the hypothalamus and possess analgesic bioactivities

      BRAIN RESEARCH
    13. Mei, JF; Pasternak, GW
      Molecular cloning and pharmacological characterization of the rat sigma(1)receptor

      BIOCHEMICAL PHARMACOLOGY
    14. Pasternak, GW
      Incomplete cross tolerance and multiple mu opioid peptide receptors

      TRENDS IN PHARMACOLOGICAL SCIENCES
    15. Abbadie, C; Gultekin, SH; Pasternak, GW
      Immunohistochemical localization of the carboxy terminus of the novel mu opioid receptor splice variant MOR-1C within the human spinal cord

      NEUROREPORT
    16. Abbadie, C; Pan, YX; Drake, CT; Pasternak, GW
      Comparative immunohistochemical distributions of carboxy terminus epitopesfrom the mu-opioid receptor splice variants MOR-1D, MOR-1 and MOR-1C in the mouse and rat CNS

      NEUROSCIENCE
    17. Pasternak, GW; Pan, YX
      Antisense mapping: Assessing functional significance of genes and splice variants

      ANTISENSE TECHNOLOGY, PT B
    18. Kolesnikov, YA; Chereshnev, I; Pasternak, GW
      Analgesic synergy between topical lidocaine and topical opioids

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    19. Letchworth, SR; Mathis, JP; Rossi, GC; Bodnar, RJ; Pasternak, GW
      Autoradiographic localization of I-125[Tyr(14)]orphanin FQ/nociceptin and I-125[Tyr(10)]orphanin FQ/nociceptin(1-11) binding sites in rat brain

      JOURNAL OF COMPARATIVE NEUROLOGY
    20. Abbadie, C; Pan, YX; Pasternak, GW
      Differential distribution in rat brain of mu opioid receptor carboxy terminal splice variants MOR-1C-like and MOR-1-like immunoreactivity: Evidence for region-specific processing

      JOURNAL OF COMPARATIVE NEUROLOGY
    21. Pan, YX; Xu, J; Bolan, E; Chang, A; Mahurter, L; Rossi, G; Pasternak, GW
      Isolation and expression of a novel alternatively spliced mu opioid receptor isoform, MOR-1F

      FEBS LETTERS
    22. Silva, RM; Rossi, GC; Mathis, JP; Standifer, KM; Pasternak, GW; Bodnar, RJ
      Morphine and morphine-6 beta-glucuronide-induced feeding are differentially reduced by G-protein alpha-subunit antisense probes in rats

      BRAIN RESEARCH
    23. Stein, JA; Znamensky, V; Baumer, F; Rossi, GC; Pasternak, GW; Bodnar, RJ
      Mercaptoacetate induces feeding through central opioid-mediated mechanismsin rats

      BRAIN RESEARCH
    24. Schuller, AGP; King, MA; Zhang, JW; Bolan, E; Pan, YX; Morgan, DJ; Chang, A; Czick, ME; Unterwald, EM; Pasternak, GW; Pintar, JE
      Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1

      NATURE NEUROSCIENCE
    25. Zhu, YX; King, MA; Schuller, AGP; Nitsche, JF; Reidl, M; Elde, RP; Unterwald, E; Pasternak, GW; Pintar, JE
      Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice

      NEURON
    26. Mathis, JP; Goldberg, IE; Letchworth, SR; Ryan-Moro, JP; Pasternak, GW
      Identification of a high-affinity orphanin FQ/Nociceptin(1-11) binding site in mouse brain

      SYNAPSE
    27. Hom, JSH; Goldberg, I; Mathis, J; Pan, YX; Brooks, AI; Ryan-Moro, J; Scheinberg, DA; Pasternak, GW
      [I-125]Orphanin FQ/nociceptin binding in Raji cells

      SYNAPSE
    28. Pan, YX; Xu, J; Bolan, E; Abbadie, C; Chang, A; Zuckerman, A; Rossi, G; Pasternak, GW
      Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms

      MOLECULAR PHARMACOLOGY
    29. Kolesnikov, YA; Pasternak, GW
      Peripheral orphanin FQ/Nociceptin analgesia in the mouse

      LIFE SCIENCES
    30. Kolesnikov, Y; Pasternak, GW
      Topical opioids in mice: Analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    31. Walker, JR; King, M; Izzo, E; Koob, GF; Pasternak, GW
      Antagonism of heroin and morphine self-administration in rats by the morphine-6 beta-glucuronide antagonist 3-O-methylnaltrexone

      EUROPEAN JOURNAL OF PHARMACOLOGY
    32. Kolesnikov, YA; Pasternak, GW
      Peripheral blockade of topical morphine tolerance by ketamine

      EUROPEAN JOURNAL OF PHARMACOLOGY
    33. Zuckerman, A; Bolan, E; de Paulis, T; Schmidt, D; Spector, S; Pasternak, GW
      Pharmacological characterization of morphine-6-sulfate and codeine-6-sulfate

      BRAIN RESEARCH
    34. Pasternak, KR; Rossi, GC; Zuckerman, A; Pasternak, GW
      Antisense mapping KOR-1: evidence for multiple kappa analgesic mechanisms

      BRAIN RESEARCH
    35. ROSSI GC; MATHIS JP; PASTERNAK GW
      ANALGESIC ACTIVITY OF ORPHANIN FQ2, MURINE PREPRO-ORPHANIN FQ(141-157') IN MICE

      NeuroReport
    36. CHARTON M; CISZEWSKA GR; GINOS J; STANDIFER KM; BROOKS AI; BROWN GP; RYANMORO JP; PASTERNAK GW
      QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS FOR SUBSTITUTED NALOXONE BENZOYLHYDRAZONES - 4'-SUBSTITUTED NALOXONE BENZOYLHYDRAZONES

      Quantitative structure-activity relationships
    37. PASTERNAK GW
      THE CENTRAL QUESTIONS IN PAIN PERCEPTION MAY BE PERIPHERAL

      Proceedings of the National Academy of Sciences of the United Statesof America
    38. MATHIS JP; GOLDBERG IE; ROSSI GC; LEVENTHAL L; PASTERNAK GW
      ANTINOCICEPTIVE ANALOGS OF ORPHANIN FQ NOCICEPTIN(1-11)/

      Life sciences (1973)
    39. LEVENTHAL L; SILVA RM; ROSSI GC; PASTERNAK GW; BODNAR RJ
      MORPHINE-6-BETA-GLUCURONIDE-INDUCED HYPERPHAGIA - CHARACTERIZATION OFOPIOID ACTION BY SELECTIVE ANTAGONISTS AND ANTISENSE MAPPING IN RATS

      The Journal of pharmacology and experimental therapeutics
    40. GOLDBERG IE; ROSSI GC; LETCHWORTH SR; MATHIS JP; RYANMORO J; LEVENTHAL L; SU W; EMMEL D; BOLAN EA; PASTERNAK GW
      PHARMACOLOGICAL CHARACTERIZATION OF ENDOMORPHIN-1 AND ENDOMORPHIN-2 IN MOUSE-BRAIN

      The Journal of pharmacology and experimental therapeutics
    41. BROWN GP; PASTERNAK GW
      H-3-NALOXONE BENZOYLHYDRAZONE BINDING IN MOR-1-TRANSFECTED CHINESE-HAMSTER OVARY CELLS - EVIDENCE FOR G-PROTEIN-DEPENDENT ANTAGONIST BINDING

      The Journal of pharmacology and experimental therapeutics
    42. KOLESNIKOV Y; JAIN S; WILSON R; PASTERNAK GW
      LACK OF MORPHINE AND ENKEPHALIN TOLERANCE IN 129 SVEV MICE - EVIDENCEFOR A NMDA RECEPTOR DEFECT/

      The Journal of pharmacology and experimental therapeutics
    43. PAN YX; MEI JF; XU J; WAN BL; ZUCKERMAN A; PASTERNAK GW
      CLONING AND CHARACTERIZATION OF A MOUSE SIGMA(1) RECEPTOR

      Journal of neurochemistry
    44. PAN YX; XU J; WAN BL; ZUCKERMAN A; PASTERNAK GW
      IDENTIFICATION AND DIFFERENTIAL REGIONAL EXPRESSION OF KOR-3 ORL-1 GENE SPLICE VARIANTS IN MOUSE-BRAIN/

      FEBS letters
    45. CHANG A; EMMEL DW; ROSSI GC; PASTERNAK GW
      METHADONE ANALGESIA IN MORPHINE-INSENSITIVE CXBK MICE

      European journal of pharmacology
    46. LEVENTHAL L; MATHIS JP; ROSSI GC; PASTERNAK GW; BODNAR RJ
      ORPHAN OPIOID RECEPTOR ANTISENSE PROBES BLOCK ORPHANIN FQ-INDUCED HYPERPHAGIA

      European journal of pharmacology
    47. KRZANOWSKA EK; ROSSI GC; PASTERNAK GW; BODNAR RJ
      POTENCY RATIOS OF MORPHINE AND MORPHINE-6-BETA-GLUCURONIDE ANALGESIA ELICITED FROM THE PERIAQUEDUCTAL GRAY, LOCUS-COERULEUS OR ROSTRAL VENTROMEDIAL MEDULLA OF RATS

      Brain research
    48. BURDICK K; YU WZ; RAGNAUTH A; MOROZ M; PAN YX; ROSSI GC; PASTERNAK GW; BODNAR RJ
      ANTISENSE MAPPING OF OPIOID RECEPTOR CLONES - EFFECTS UPON 2-DEOXY-D-GLUCOSE-INDUCED HYPERPHAGIA

      Brain research
    49. ROSSI GC; PERLMUTTER M; LEVENTHAL L; TALATTI A; PASTERNAK GW
      ORPHANIN FQ NOCICEPTIN ANALGESIA IN THE RAT

      Brain research
    50. KING M; CHANG A; PASTERNAK GW
      FUNCTIONAL BLOCKADE OF OPIOID ANALGESIA BY ORPHANIN FQ NOCICEPTIN/

      Biochemical pharmacology
    51. Payne, R; Pasternak, GW
      Pain

      PHARMACOLOGICAL MANAGEMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
    52. STANDIFER KM; PASTERNAK GW
      G-PROTEINS AND OPIOID RECEPTOR-MEDIATED SIGNALING

      Cellular signalling
    53. KING MA; ROSSI GC; CHANG AH; WILLIAMS L; PASTERNAK GW
      SPINAL ANALGESIC ACTIVITY OF ORPHANIN FQ NOCICEPTIN AND ITS FRAGMENTS/

      Neuroscience letters
    54. KOLESNIKOV Y; JAIN S; WILSON R; PASTERNAK GW
      BLOCKADE OF MORPHINE-INDUCED HINDLIMB MYOCLONIC SEIZURES IN MICE BY KETAMINE

      Pharmacology, biochemistry and behavior
    55. KOLESNIKOV YA; PAN YX; BABEY AM; JAIN S; WILSON R; PASTERNAK GW
      FUNCTIONALLY DIFFERENTIATING 2 NEURONAL NITRIC-OXIDE SYNTHASE ISOFORMS THROUGH ANTISENSE MAPPING - EVIDENCE FOR OPPOSING NO ACTIONS ON MORPHINE ANALGESIA AND TOLERANCE

      Proceedings of the National Academy of Sciences of the United Statesof America
    56. BROWN GP; YANG K; OUERFELLI O; STANDIFER KM; BYRD D; PASTERNAK GW
      H-3 MORPHINE-6-BETA-GLUCURONIDE BINDING IN BRAIN MEMBRANES AND AN MOR-1-TRANSFECTED CELL-LINE

      The Journal of pharmacology and experimental therapeutics
    57. LEVENTHAL L; STEVENS LB; ROSSI GC; PASTERNAK GW; BODNAR RJ
      ANTISENSE MAPPING OF THE MOR-1 OPIOID RECEPTOR CLONE - MODULATION OF HYPERPHAGIA INDUCED BY DAMGO

      The Journal of pharmacology and experimental therapeutics
    58. ROSSI GC; LEVENTHAL L; BOLAN E; PASTERNAK GW
      PHARMACOLOGICAL CHARACTERIZATION OF ORPHANIN FQ NOCICEPTIN AND ITS FRAGMENTS/

      The Journal of pharmacology and experimental therapeutics
    59. ROSSI GC; LEVENTHAL L; PAN YX; COLE J; SU W; BODNAR RJ; PASTERNAK GW
      ANTISENSE MAPPING OF MOR-1 IN RATS - DISTINGUISHING BETWEEN MORPHINE AND MORPHINE-6-BETA-GLUCURONIDE ANTINOCICEPTION

      The Journal of pharmacology and experimental therapeutics
    60. BROWN GP; YANG K; KING MA; ROSSI GC; LEVENTHAL L; CHANG A; PASTERNAK GW
      3-METHOXYNALTREXONE, A SELECTIVE HEROIN MORPHINE-6-BETA-GLUCURONIDE ANTAGONIST/

      FEBS letters
    61. KING M; PAN YX; MEI JF; CHANG A; XU J; PASTERNAK GW
      ENHANCED KAPPA-OPIOID RECEPTOR-MEDIATED ANALGESIA BY ANTISENSE TARGETING THE SIGMA(1) RECEPTOR

      European journal of pharmacology
    62. CHIEN CC; CARROLL FI; BROWN GP; PAN YX; BOWEN W; PASTERNAK GW
      SYNTHESIS AND CHARACTERIZATION OF [I-125] 3'-(-)-IODOPENTAZOCINE, A SELECTIVE SIGMA(1) RECEPTOR-LIGAND

      European journal of pharmacology
    63. ROSSI GC; SU W; LEVENTHAL L; SU H; PASTERNAK GW
      ANTISENSE MAPPING DOR-1 IN MICE - FURTHER SUPPORT FOR DELTA-RECEPTOR SUBTYPES

      Brain research
    64. MATHIS JP; RYANMORO J; CHANG A; HOM JSH; SCHEINBERG DA; PASTERNAK GW
      BIOCHEMICAL-EVIDENCE FOR ORPHANIN FQ NOCICEPTIN RECEPTOR HETEROGENEITY IN MOUSE-BRAIN/

      Biochemical and biophysical research communications
    65. KHANOLKAR AD; YIN DL; MAKRIYANNIS A; BROOKS AI; PASTERNAK GW; FROIMOWITZ M
      THE MORPHINE-LIKE AND NONMORPHINE-LIKE CONFORMERS OF PRODINE OPIOIDS

      Medicinal chemistry research
    66. PASTERNAK GW
      HOT PAPERS - MOLECULAR NEUROPHARMACOLOGY - SELECTIVE LOSS OF DELTA-OPIOID ANALGESIA AND BINDING OF DELTA-OPIOID ANALGESIA AND BINDING BY ANTISENSE OLIGODEOXYNUCLEOTIDE TO A DELTA-OPIOID RECEPTOR BY STANDIFER,K.M., CHIEN,C.C., WAHLESTEDT,C., BROWN,G.P., PASTERNAK,G.W. - COMMENTS

      The Scientist
    67. CISZEWSKA GR; GINOS JA; CHARTON M; STANDIFER KM; BROOKS AI; BROWN GP; RYANMORO JP; BERZETEIGURSKE I; TOLL L; PASTERNAK GW
      SYNTHESIS AND CHARACTERIZATION OF SUBSTITUTED BENZOYLHYDRAZONES OF NALOXONE

      Synapse
    68. BROOKS AI; STANDIFER KM; ROSSI GC; MATHIS JP; PASTERNAK GW
      CHARACTERIZING KAPPA(3) OPIOID RECEPTORS WITH A SELECTIVE MONOCLONAL-ANTIBODY

      Synapse
    69. PAN YX; XU J; PASTERNAK GW
      STRUCTURE AND CHARACTERIZATION OF THE GENE ENCODING A MOUSE KAPPA(3)-RELATED OPIOID RECEPTOR

      Gene
    70. RYANMORO J; CHIEN CC; STANDIFER KM; PASTERNAK GW
      SIGMA(1) BINDING IN A HUMAN NEUROBLASTOMA CELL-LINE

      Neurochemical research
    71. ROSSI GC; BROWN GP; LEVENTHAL L; YANG K; PASTERNAK GW
      NOVEL RECEPTOR MECHANISMS FOR HEROIN AND MORPHINE-6-BETA-GLUCURONIDE ANALGESIA

      Neuroscience letters
    72. PAN YX; XU J; PASTERNAK GW
      CLONING AND EXPRESSION OF A CDNA-ENCODING A MOUSE-BRAIN ORPHANIN FQ NOCICEPTIN PRECURSOR

      Biochemical journal
    73. STANDIFER KM; ROSSI GC; PASTERNAK GW
      DIFFERENTIAL BLOCKADE OF OPIOID ANALGESIA BY ANTISENSE OLIGODEOXYNUCLEOTIDES DIRECTED AGAINST VARIOUS G-PROTEIN ALPHA-SUBUNITS

      Molecular pharmacology
    74. KOLESNIKOV YA; JAIN S; WILSON R; PASTERNAK GW
      PERIPHERAL MORPHINE ANALGESIA - SYNERGY WITH CENTRAL SITES AND A TARGET OF MORPHINE-TOLERANCE

      The Journal of pharmacology and experimental therapeutics
    75. PAN YX; XU J; RYANMORO J; MATHIS J; HOM JSH; MEI JF; PASTERNAK GW
      DISSOCIATION OF AFFINITY AND EFFICACY IN KOR-3 CHIMERAS

      FEBS letters
    76. ROSSI GC; LEVENTHAL L; PASTERNAK GW
      NALOXONE SENSITIVE ORPHANIN FQ-INDUCED ANALGESIA IN MICE

      European journal of pharmacology
    77. KOLESNIKOV Y; JAIN S; WILSON R; PASTERNAK GW
      PERIPHERAL KAPPA(1)-OPIOID RECEPTOR-MEDIATED ANALGESIA IN MICE

      European journal of pharmacology
    78. KOLESNIKOV Y; JAIN S; PASTERNAK GW
      MODULATION OF OPIOID ANALGESIA BY AGMATINE

      European journal of pharmacology
    79. PASTERNAK GW; STANDIFER KM
      ORPHAN RECEPTOR OR KAPPA(3)-OPIOID RECEPTOR - REPLY

      Trends in pharmacological sciences
    80. PASTERNAK GW; KOLESNIKOV YA; BABEY AM
      PERSPECTIVES ON THE N-METHYL-D-ASPARTATE NITRIC-OXIDE CASCADE AND OPIOID TOLERANCE

      Neuropsychopharmacology
    81. ROSSI GC; STANDIFER KM; PASTERNAK GW
      DIFFERENTIAL BLOCKADE OF MORPHINE AND MORPHINE-6-BETA-GLUCURONIDE ANALGESIA BY ANTISENSE OLIGODEOXYNUCLEOTIDES DIRECTED AGAINST MOR-1 AND G-PROTEIN ALPHA-SUBUNITS IN RATS

      Neuroscience letters
    82. CHIEN CC; PASTERNAK GW
      SIGMA-ANTAGONISTS POTENTIATE OPIOID ANALGESIA IN RATS

      Neuroscience letters
    83. PAN YX; CHENG J; XU J; ROSSI G; JACOBSON E; RYANMORO J; BROOKS AI; DEAN GE; STANDIFER KM; PASTERNAK GW
      CLONING AND FUNCTIONAL-CHARACTERIZATION THROUGH ANTISENSE MAPPING OF A KAPPA(3)-RELATED OPIOID RECEPTOR

      Molecular pharmacology
    84. STANDIFER KM; JENAB S; SU W; CHIEN CC; PAN YX; INTURRISI CE; PASTERNAK GW
      ANTISENSE OLIGODEOXYNUCLEOTIDES TO THE CLONED DELTA-RECEPTOR DOR-1 - UPTAKE, STABILITY, AND REGULATION OF GENE-EXPRESSION

      Journal of neurochemistry
    85. CHENG J; STANDIFER KM; TUBLIN PR; SU W; PASTERNAK GW
      DEMONSTRATION OF KAPPA(3)-OPIOID RECEPTORS IN THE SH-SY5Y HUMAN NEUROBLASTOMA CELL-LINE

      Journal of neurochemistry
    86. ROSSI GC; PAN YX; BROWN GP; PASTERNAK GW
      ANTISENSE MAPPING THE MOR-1 OPIOID RECEPTOR - EVIDENCE FOR ALTERNATIVE SPLICING AND A NOVEL MORPHINE-6-BETA-GLUCURONIDE RECEPTOR

      FEBS letters
    87. CHIEN CC; PASTERNAK GW
      (-)-PENTAZOCINE ANALGESIA IN MICE - INTERACTIONS WITH A SIGMA-RECEPTOR SYSTEM

      European journal of pharmacology
    88. BERZETEIGURSKE IP; WHITE A; POLGAR W; DECOSTA BR; PASTERNAK GW; TOLL L
      THE IN-VITRO PHARMACOLOGICAL CHARACTERIZATION OF NALOXONE BENZOYLHYDRAZONE

      European journal of pharmacology
    89. COLE JL; LEVENTHAL L; PASTERNAK GW; BOWEN WD; BODNAR RJ
      REDUCTIONS IN BODY-WEIGHT FOLLOWING CHRONIC CENTRAL OPIOID RECEPTOR SUBTYPE ANTAGONISTS DURING DEVELOPMENT OF DIETARY OBESITY IN RATS

      Brain research
    90. PASTERNAK GW; STANDIFER KM
      MAPPING OF OPIOID RECEPTORS USING ANTISENSE OLIGODEOXYNUCLEOTIDES - CORRELATING THEIR MOLECULAR-BIOLOGY AND PHARMACOLOGY

      Trends in pharmacological sciences
    91. BROOKS AI; STANDIFER KM; CHENG J; CISZEWSKA G; PASTERNAK GW
      OPIOID BINDING IN GIANT TOAD AND GOLDFISH BRAIN

      Receptor
    92. STANDIFER KM; CHIEN CC; WAHLESTEDT C; BROWN GP; PASTERNAK GW
      SELECTIVE LOSS OF DELTA-OPIOID ANALGESIA AND BINDING BY ANTISENSE OLIGODEOXYNUCLEOTIDES TO A DELTA-OPIOID RECEPTOR

      Neuron
    93. ELLIOTT K; MINAMI N; KOLESNIKOV YA; PASTERNAK GW; INTURRISI CE
      THE NMDA RECEPTOR ANTAGONISTS, LY274614 AND MK-801, AND THE NITRIC-OXIDE SYNTHASE INHIBITOR, NG-NITRO-L-ARGININE, ATTENUATE ANALGESIC TOLERANCE TO THE MU-OPIOID MORPHINE BUT NOT TO KAPPA-OPIOIDS

      Pain
    94. VISCONTI LM; STANDIFER KM; SCHILLER PW; PASTERNAK GW
      TIPP[PSI], A HIGHLY SELECTIVE DELTA-LIGAND

      Neuroscience letters
    95. LAI J; BILSKY EJ; BERNSTEIN RN; ROTHMAN RB; PASTERNAK GW; PORRECA F
      ANTISENSE OLIGODEOXYNUCLEOTIDE TO THE CLONED DELTA-OPIOID RECEPTOR SELECTIVELY INHIBITS SUPRASPINAL, BUT NOT SPINAL, ANTINOCICEPTIVE EFFECTS OF [D-ALA(2),GLU(4)]DELTORPHIN

      Regulatory peptides
    96. PAN YX; CHENG J; XU J; PASTERNAK GW
      CLONING, EXPRESSION AND CLASSIFICATION OF A KAPPA(3)-RELATED OPIOID RECEPTOR USING ANTISENSE OLIGODEOXYNUCLEOTIDES

      Regulatory peptides
    97. PASTERNAK GW
      ANTI-OPIOID ACTIVITY OF SIGMA(1) SYSTEMS

      Regulatory peptides
    98. LIPKOWSKI AW; PASTERNAK GW; MISTEREK K; GUMULKA SW; PACHOCKA M
      SYNTHESIS AND BIOLOGICAL PROPERTIES OF NEW NALTREXONE-PEPTIDE HYBRIDS

      Regulatory peptides
    99. DOOLEY CT; CHUNG NN; WILKES BC; SCHILLER PW; BIDLACK JM; PASTERNAK GW; HOUGHTEN RA
      AN ALL D-AMINO-ACID OPIOID PEPTIDE WITH CENTRAL ANALGESIC ACTIVITY FROM A COMBINATORIAL LIBRARY

      Science
    100. BABEY AM; KOLESNIKOV Y; CHENG J; INTURRISI CE; TRIFILLETTI RR; PASTERNAK GW
      NITRIC-OXIDE AND OPIOID TOLERANCE

      Neuropharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/05/20 alle ore 23:30:05